Barclays »

Stoke Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $206k 39k 5.25
2023-09-30 $33k 8.4k 3.91
2023-06-30 $157k 15k 10.59
2023-03-31 $190k 23k 8.33
2022-12-31 $170k 18k 9.20
2022-09-30 $135k 11k 12.78
2022-06-30 $131k 9.9k 13.24
2022-03-31 $98k 4.7k 20.89
2021-12-31 $556k 23k 24.00
2021-09-30 $233k 9.2k 25.41
2021-06-30 $370k 11k 33.60
2021-03-31 $686k 18k 38.87
2020-12-31 $318k 5.1k 61.97
2020-09-30 $229k 6.8k 33.56
2020-06-30 $239k 10k 23.96
2020-03-31 $142k 6.2k 22.83
2019-12-31 $278k 9.8k 28.30
2019-09-30 $129k 6.0k 21.45
2019-06-30 $27k 914 29.54